Predicting cytotoxicity of PAMAM dendrimers using molecular descriptors
Source abstract
Abstract
The use of data mining techniques in the field of nanomedicine has been very limited. In this paper we demonstrate that data mining techniques can be used for the development of predictive models of the cytotoxicity of poly(amido amine) (PAMAM) dendrimers using their chemical and structural properties. We present predictive models developed using 103 PAMAM dendrimer cytotoxicity values that were extracted from twelve cancer nanomedicine journal articles. The results indicate that data mining and machine learning can be effectively used to predict the cytotoxicity of PAMAM dendrimers on Caco-2 cells.
Source: crossref · Quality: baseline
Research context
OpenAlex topics: Dendrimers and Hyperbranched Polymers · Computational Drug Discovery Methods · Chemical Synthesis and Analysis
SciVX discovery tags are terminology-based. OpenAlex topics are source-provided classifications.
References (43)
Show source-provided references
1. 10.2174/13816120778279425710.2174/138161207782794257 ↗
2. 10.1016/j.jbi.2010.03.00110.1016/j.jbi.2010.03.001 ↗
3. 10.2147/IJN.S4074210.2147/IJN.S40742 ↗
4. 10.1186/1743-8977-10-3210.1186/1743-8977-10-32 ↗
5. 10.1111/j.1539-6924.2010.01438.x10.1111/j.1539-6924.2010.01438.x ↗
6. 10.1371/journal.pone.008393210.1371/journal.pone.0083932 ↗
7. 10.1016/j.addr.2011.09.00110.1016/j.addr.2011.09.001 ↗
8. 10.1016/j.addr.2009.11.00810.1016/j.addr.2009.11.008 ↗
9. 10.1002/adma.20090265810.1002/adma.200902658 ↗
10. 10.2174/18722110778083194110.2174/187221107780831941 ↗
11. 10.1093/nar/24.11.217610.1093/nar/24.11.2176 ↗
12. 10.1021/ma00044a01310.1021/ma00044a013 ↗
13. 10.1016/S0378-5173(03)00225-410.1016/S0378-5173(03)00225-4 ↗
14. 10.1002/anie.20050215210.1002/anie.200502152 ↗
15. 10.3109/17435390.2011.60444210.3109/17435390.2011.604442 ↗
16. 10.1016/j.ejpb.2013.01.01910.1016/j.ejpb.2013.01.019 ↗
17. 10.2174/13816121079192046910.2174/138161210791920469 ↗
18. 10.1517/1742524090306125110.1517/17425240903061251 ↗
19. 10.1145/1656274.165627810.1145/1656274.1656278 ↗
20. 10.1007/3-540-59286-5_5710.1007/3-540-59286-5_57 ↗
21. 10.1177/088391150301800100210.1177/0883911503018001002 ↗
22. 10.1016/j.jconrel.2010.11.02210.1016/j.jconrel.2010.11.022 ↗
23. 10.1016/S0378-5173(02)00623-310.1016/S0378-5173(02)00623-3 ↗
24. 10.1002/jps.2115510.1002/jps.21155 ↗
25. 10.1007/s11095-007-9415-010.1007/s11095-007-9415-0 ↗
26. 10.1021/mp700089s10.1021/mp700089s ↗
27. 10.1021/bc060388910.1021/bc0603889 ↗
28. 10.1016/j.ijpharm.2006.11.04710.1016/j.ijpharm.2006.11.047 ↗
29. 10.1016/j.ijpharm.2007.08.03310.1016/j.ijpharm.2007.08.033 ↗
30. 10.2147/IJN.S3278510.2147/IJN.S32785 ↗
31. 10.1016/j.jconrel.2009.04.02210.1016/j.jconrel.2009.04.022 ↗
32. 10.1016/j.ijpharm.2012.10.02410.1016/j.ijpharm.2012.10.024 ↗
33. 10.1021/bc060325q10.1021/bc060325q ↗
34. 10.1016/B978-0-12-374856-0.00025-010.1016/B978-0-12-374856-0.00025-0 ↗
35. Schölkopf · 1998
36. Quinlan · 1993
37. 10.1023/A:101805431435010.1023/A:1018054314350 ↗
38. 10.1023/A:100742130214910.1023/A:1007421302149 ↗
39. Frank · 2003 · 249
40. Kohavi · 1995
41. Hall · 2008 · 318
42. Kohavi · 1996 · 202
43. 10.1007/b10740810.1007/b107408 ↗